Skip to content
  • Home
  • About
  • News
    • Top
    • Recent News
    • Archive
  • Account
    • Profile
    • Manage Corporate Account
    • Orders
    • Billing
    • Cancel
  • Subscription Plans
  • Contact
  • Login
  • Home
  • About
  • News
    • Top
    • Recent News
    • Archive
  • Account
    • Profile
    • Manage Corporate Account
    • Orders
    • Billing
    • Cancel
  • Subscription Plans
  • Contact
  • Login

Generic Semaglutide Pricing Could Disrupt Global Markets

Generic Semaglutide Pricing Could Disrupt Global Markets

Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

GLP-1 Medicines Review: South Africa Moves to Expand Access

NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

A decade of transformation in obesity treatment

ObesityWeek 2024 attracted unprecedented attention from Wall Street, highlighting obesity treatment's booming pharmaceutical industry.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Aspen secures licensing agreement to enter GLP-1 market

Aspen Pharmacare has secured a licensing agreement to enter the GLP-1 agonist market, positioning it for growth in diabetes and obesity treatment solutions.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here